WHO endorses ICMR's Truenat tests to detect TB, rifampicin r
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
In a joint statement, the Foundation for Innovative New Diagnostics (FIND), Molbio Diagnostics and the Indian Council of Medical Research (ICMR) said the WHO has now endorsed three of their rapid molecular Truenat TM assays for initial diagnosis of TB and subsequent detection of rifampicin resistance in adults and children.

"Both Truenat MTB and Truenat MTB Plus detect Mycobacterium tuberculosis bacteria for TB diagnosis, while Truenat MTB-RIF Dx identifies resistance to rifampicin, the most commonly used first-line treatment."

"All three tests are run on the portable, battery-operated Truenat device and provide results in less than an hour," they said in a statement.

"Endorsement of Truenat by WHO will enable other low-and middle-income countries to procure Truenat for diagnosis of TB and rifampicin resistance, thus supporting TB elimination in developing countries," the statement quoting Balram Bhargava, Secretary DHR and Director General - ICMR said.

Source:https://www.business-standard.com/article/current-affairs/who-endorses-icmr-s-truenat-tests-to-detect-tb-rifampicin-resistance-120070301186_1.html
N●●a R●●●●●r and 9 others like this5 shares
Like
Comment
Share
Dr. R S C●●●●●n
Dr. R S C●●●●●n Internal Medicine
Is it commercially available?
Jul 5, 2020Like